Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when co-administered with dual or selective CYP2C9 and CYP3A interacting drugs.

about

Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when co-administered with dual or selective CYP2C9 and CYP3A interacting drugs.

Item

http://www.wikidata.org/entity/Q48228832

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetic/pharmacodynami ...... 9 and CYP3A interacting drugs.

@en

Pharmacokinetic/pharmacodynami ...... 9 and CYP3A interacting drugs.

@nl

type

Item

label

Pharmacokinetic/pharmacodynami ...... 9 and CYP3A interacting drugs.

@en

Pharmacokinetic/pharmacodynami ...... 9 and CYP3A interacting drugs.

@nl

prefLabel

Pharmacokinetic/pharmacodynami ...... 9 and CYP3A interacting drugs.

@en

Pharmacokinetic/pharmacodynami ...... 9 and CYP3A interacting drugs.

@nl

P1476

Pharmacokinetic/pharmacodynami ...... C9 and CYP3A interacting drugs

@en

P2093

Bhaskar Rege

http://www.w3.org/2001/XMLSchema#string

Cynthia A Zamora

http://www.w3.org/2001/XMLSchema#string

Edgar Schuck

http://www.w3.org/2001/XMLSchema#string

Jagadeesh Aluri

http://www.w3.org/2001/XMLSchema#string

Jim Ferry

http://www.w3.org/2001/XMLSchema#string

Min-Kun Chang

http://www.w3.org/2001/XMLSchema#string

Peter Boyd

http://www.w3.org/2001/XMLSchema#string

Sanae Yasuda

http://www.w3.org/2001/XMLSchema#string

W George Lai

http://www.w3.org/2001/XMLSchema#string

Y Amy Siu

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.

AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects.

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.

Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies.

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.

Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies.

P304

952-960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13517

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maiko Nomoto

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29341245

http://www.w3.org/2001/XMLSchema#string

P932

5903264

http://www.w3.org/2001/XMLSchema#string